Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-09

Clinical Trial Results: Dose-Escalation Study of HTX-034 Following Bunionectomy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-escalation study of HTX-034 for bunion surgery postoperative pain completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HTX-034

Snippet

Sponsor: Heron Therapeutics | Conditions: Bunions, Postoperative Pain | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-06-09